Biotime is pleased to announce its participation in WHX & WHX Lab 2026, one of Southeast Asia's premier healthcare and laboratory exhibitions. The event will take place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, where Biotime will be exhibiting at Booth L27.

As an innovator in the in vitro diagnostics (IVD) industry, Biotime is committed to delivering fast, accurate, and reliable diagnostic solutions to healthcare providers, laboratories, and distribution partners worldwide. At this year's show, the company will showcase two core technology platforms:

Chemiluminescence Immunoassay Platform–featuring high sensitivity and high throughput, designed for automated testing in medium to large-scale laboratories.

Fluorescence Immunoassay Platform–offering flexibility and user-friendly operation, well-suited for primary care and point-of-care testing (POCT) settings.

Built upon these platforms, Biotime has developed a comprehensive test menu covering multiple disease areas, including:

• Thyroid function
• Cardiovascular markers
• Diabetes management
• Infectious diseases
• Tumor markers

The Bangkok exhibition represents a strategic step in Biotime's ongoing expansion into the Southeast Asian market. Beyond product demonstrations, the company looks forward to engaging with industry professionals from Thailand and neighboring countries, gaining insights into local healthcare needs, and exploring collaborative opportunities to strengthen regional diagnostic capabilities.

Whether you are a laboratory professional, distributor, or clinician, Biotime welcomes you to Booth L27 for technical presentations, product demonstrations, and in-depth discussions on the future of diagnostics.